| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.003 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.76 | 0.004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |